11:59 AM EDT, 03/25/2025 (MT Newswires) -- GSK (GSK) is collaborating with the UK Dementia Research Institute and Health Data Research UK for a dementia study that aims to advance the understanding of neurodegeneration.

The project will look into a potential association between GSK's shingles vaccine, Recombinant Zoster Vaccine, and a reduced dementia risk, using the UK's health data ecosystem.

The collaboration, if successful, may be a blueprint for population level health data research models, GSK said Tuesday in a statement.

Price: 38.80, Change: +0.23, Percent Change: +0.58